Concepedia
Statistics
Publications
8
Citations
364
H-Index
Active since
2015
Affiliations
University of Basel(Current)
Heidelberg University
University Hospital Heidelberg
Roche (Denmark)
University of British Columbia
Philip Grossen is an author at University of Basel specializing in pharmacy, drug delivery, and nanomedicine.
Publications per year
2015–2021
Zebrafish as an early stage screening tool to study the systemic circulation of nanoparticulate drug delivery systems in vivo
Sandro Sieber, Philip Grossen, Pascal Detampel et al. · Journal of Controlled Release · 2017 · 101 citations
Pharmacy, Pharmaceutics, Pharmacokinetics +16
Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology
Nikhil J. Pandya, Congwei Wang, Veronica Costa et al. · Cell Reports Medicine · 2021 · 67 citations · Full text
Life Sciences, Molecular Biology, Neuroscience +15
Evaluation of bovine milk extracellular vesicles for the delivery of locked nucleic acid antisense oligonucleotides
Philip Grossen, Michaela Portmann, Erich Koller et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2020 · 54 citations
Pharmacy, Biotechnology, Molecular Biology +14
Zebrafish as a predictive screening model to assess macrophage clearance of liposomes in vivo
Sandro Sieber, Philip Grossen, Philipp Uhl et al. · Nanomedicine Nanotechnology Biology and Medicine · 2019 · 51 citations · Full text
Pharmacy, Molecular Pharmaceutics, Pharmaceutics +16
PDMS-b-PMOXA polymersomes for hepatocyte targeting and assessment of toxicity
Klara Kiene, Susanne Schenk, Fabiola Porta et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2017 · 32 citations
Pharmacy, Pharmaceutics, Toxicology +13
1–5 of 8